Journal Watch · Frontiers in Immunology · 2026

Treg cells protect astrocytes from ferroptosis after subarachnoid hemorrhage by activating the HIF-1α/Hmox1 pathway.

They thereby limit oxidative damage that depends on iron and preserve astrocyte integrity.

Huang L, Yao Z, Meng F et al.Frontiers in Immunology4 min readPharma relevance 60/100

DOI: 10.3389/fimmu.2026.1825459PMID: 42253952Study type: preclinical (animal / model) study

TL;DR

They thereby limit oxidative damage that depends on iron and preserve astrocyte integrity.

Key findings

  • Tregcells rapidly accumulated after SAH, and enhancement of their function significantly improved neurological outcomes.Transcriptomic profiling of astrocytes revealed that the interaction between Tregcells and astrocyte selectively enriched ferroptosis pathways, with prominent activation of HIF-1α signaling and robust upregulation of Hmox1.
  • Mechanistically, Tregcells promoted a distinct regulatory pattern characterized by moderate stabilization of HIF-1α but disproportionately enhanced Hmox1 expression.
  • Importantly, Tregcells did not induce excessive activation of the HIF-1α/Hmox1 axis, indicating that they maintain this pathway within a defined protective range to suppress ferroptosis without exacerbating toxicity dependent on iron.<h4>Conclusion</h4>This study identified a previously unrecognized immunometabolic mechanism by which Tregcells constrain astrocytic ferroptosis after SAH.
  • By reinforcing an otherwise insufficient endogenous stress response, Tregcells fine tune the HIF-1α/Hmox1 axis to a protective range.
  • They thereby limit oxidative damage that depends on iron and preserve astrocyte integrity.

What they did

This knowledge gap motivated us to conduct the present studies.<h4>Methods</h4>Establish a mouse model of SAH. Using <i>in vitro</i> experiments, Tregcells were co-cultured with astrocytes, using oxygenated hemoglobin (OxyHb) to induce a pathological environment mimicking SAH. Key signaling pathways were identified through transcriptome sequencing. The effects of Tregcells on astrocytes were evaluated through AAV-mediated gene overexpression and knockdown, drug agonists and antagonists, plasmid transfection, SAH grading, neurobehavioral testing, western blotting, and immunofluorescence.<h4>Results</h4>Following SAH, the HIF-1α/Hmox1 signaling axis was activated in the brain, predominantly in astrocytes. However, this compensatory response was insufficient to prevent progressive ferroptotic injury, as indicated by sustained lipid peroxidation and iron accumulation.

Full abstract (original)

Background: <h4>Background</h4>Foxp3+ regulatory T (Treg) cells play a central role in maintaining immune homeostasis by suppressing excessive immune responses to prevent autoimmune damage. Within the nervous system, they actively inhibit neuroinflammation and promote tissue repair. Current studies have demonstrated that the number of Tregcells significantly increases following subarachnoid hemorrhage (SAH). Tregcells infiltrating into the brain after SAH can exert critical anti-inflammatory and neuroprotective effects by modulating microglia polarization. Although they are the most abundant and functionally diverse glial cells in the central nervous system, there is only limited research on the direct and specific interactions of astrocytes and Tregcells in SAH.

What they did: This knowledge gap motivated us to conduct the present studies.<h4>Methods</h4>Establish a mouse model of SAH. Using <i>in vitro</i> experiments, Tregcells were co-cultured with astrocytes, using oxygenated hemoglobin (OxyHb) to induce a pathological environment mimicking SAH. Key signaling pathways were identified through transcriptome sequencing. The effects of Tregcells on astrocytes were evaluated through AAV-mediated gene overexpression and knockdown, drug agonists and antagonists, plasmid transfection, SAH grading, neurobehavioral testing, western blotting, and immunofluorescence.<h4>Results</h4>Following SAH, the HIF-1α/Hmox1 signaling axis was activated in the brain, predominantly in astrocytes. However, this compensatory response was insufficient to prevent progressive ferroptotic injury, as indicated by sustained lipid peroxidation and iron accumulation.

Results & conclusions: Tregcells rapidly accumulated after SAH, and enhancement of their function significantly improved neurological outcomes.Transcriptomic profiling of astrocytes revealed that the interaction between Tregcells and astrocyte selectively enriched ferroptosis pathways, with prominent activation of HIF-1α signaling and robust upregulation of Hmox1. Mechanistically, Tregcells promoted a distinct regulatory pattern characterized by moderate stabilization of HIF-1α but disproportionately enhanced Hmox1 expression. Importantly, Tregcells did not induce excessive activation of the HIF-1α/Hmox1 axis, indicating that they maintain this pathway within a defined protective range to suppress ferroptosis without exacerbating toxicity dependent on iron.<h4>Conclusion</h4>This study identified a previously unrecognized immunometabolic mechanism by which Tregcells constrain astrocytic ferroptosis after SAH. By reinforcing an otherwise insufficient endogenous stress response, Tregcells fine tune the HIF-1α/Hmox1 axis to a protective range. They thereby limit oxidative damage that depends on iron and preserve astrocyte integrity.

Abstract © the authors / Frontiers in Immunology (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.3389/fimmu.2026.1825459 · PubMed 42253952.

Why it matters for pharma & biotech

  • Directly relevant to teams in small-molecule drug discovery, gene therapy — the abstract reports new data in that space, so competitive and pipeline teams should read the full text.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Modalities & themes detected: small-molecule drug discovery · gene therapy

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • The work is preclinical. Results in animal or cell models frequently do not translate directly to human efficacy or safety.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this Frontiers in Immunology study find?

They thereby limit oxidative damage that depends on iron and preserve astrocyte integrity.

What type of study is this?

It is a preclinical (animal / model) study, published in Frontiers in Immunology in 2026. This knowledge gap motivated us to conduct the present studies.<h4>Methods</h4>Establish a mouse model of SAH.

Where can I read the original paper?

The original is at the publisher via DOI 10.3389/fimmu.2026.1825459. PubMed ID: 42253952. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Huang L, Yao Z, Meng F et al.. Treg cells protect astrocytes from ferroptosis after subarachnoid hemorrhage by activating the HIF-1α/Hmox1 pathway.. Frontiers in Immunology (2026). DOI: 10.3389/fimmu.2026.1825459.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/treg-cells-protect-astrocytes-from-ferroptosis-after-subarachnoid-hemorr-825459/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides